Intra Cellular Therapies | Passività Correnti

Current Liabilities Cambiamento Data
Acadia Pharmaceuticals USD 254.25M 44.65M 2023-12
ALKERMES USD 503.11M 15.92M 2023-09
Cytokinetics USD 102.68M 24.96M 2023-12
Gilead Sciences USD 11.28B 665M 2023-12
Halozyme Therapeutics USD 112.49M 2.69M 2023-12
Intra Cellular Therapies USD 123.54M 20.45M 2023-12
Neurocrine Biosciences USD 691.6M 109.1M 2023-09
RedHill Biopharma USD 28.19M 20.25M 2023-06
Supernus Pharmaceuticals USD 290.2M 2.66M 2023-12
United Therapeutics USD 804.4M 60.3M 2023-12



Intra Cellular Therapies Passività Correnti - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Apr 2024.